Andere Kunden interessierten sich auch für
![Prostate-Specific Antigen]( "Prostate-Specific Antigen")
Prostate-Specific Antigen22,99 €![Novel Strategies for Inducing Antigen-Specific Immunological Tolerance]( "Novel Strategies for Inducing Antigen-Specific Immunological Tolerance")
Novel Strategies for Inducing Antigen-Specific Immunological Tolerance51,99 €![Patient specific instrumentation in TKR:Boon or Fad]( "Patient specific instrumentation in TKR:Boon or Fad")
Patient specific instrumentation in TKR:Boon or Fad39,99 €![Our experiences in use of autologous blood and autologous blood products]( "Our experiences in use of autologous blood and autologous blood products")
Our experiences in use of autologous blood and autologous blood products29,99 €![Our Experience in Intraoperative Autologous Blood Salvage in the Pediatric Patients]( "Our Experience in Intraoperative Autologous Blood Salvage in the Pediatric Patients")
Our Experience in Intraoperative Autologous Blood Salvage in the Pediatric Patients26,99 €![Specific weights of risk factors in low birth weight.]( "Specific weights of risk factors in low birth weight.")
Specific weights of risk factors in low birth weight.39,99 €![Diagnosing Specific Language Impairment]( "Diagnosing Specific Language Impairment")
Diagnosing Specific Language Impairment51,99 €
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Autologous Patient Specific Tumor Antigen Response technology, or apSTAR, is a new cancer treatment procedure being developed by IMULAN BioTherapeutics, LLC and Veterinary Cancer Therapeutics, LLC for comparative oncology. Also known as laser-assisted immunotherapy, apSTAR is an experimental cancer treatment for solid tumors that utilizes an autologous vaccine-like approach to stimulate immune responses. Specifically, laser-assisted immunotherapy combines laser-induced in situ tumor devitalization with an immunoadjuvant for local immunostimulation.